BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20198190)

  • 1. Genome subtraction for novel target definition in Salmonella typhi.
    Rathi B; Sarangi AN; Trivedi N
    Bioinformation; 2009 Oct; 4(4):143-50. PubMed ID: 20198190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
    Uddin R; Sufian M
    PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
    Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
    Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Novel Therapeutic Target against XDR
    Jalal K; Khan K; Hassam M; Abbas MN; Uddin R; Khusro A; Sahibzada MUK; Gajdács M
    Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics based subtractive genomics approach to decipher the therapeutic function of hypothetical proteins from Salmonella typhi XDR H-58 strain.
    Khan K; Uddin R
    Biotechnol Lett; 2022 Feb; 44(2):279-298. PubMed ID: 35037232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
    Kumar A; Thotakura PL; Tiwary BK; Krishna R
    BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome Exploration of
    Khan MT; Mahmud A; Hasan M; Azim KF; Begum MK; Rolin MH; Akter A; Mondal SI
    Microbiol Spectr; 2022 Aug; 10(4):e0037322. PubMed ID: 35863001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
    Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
    Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of potential drug targets by subtractive genome analyses of methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K
    Comput Biol Chem; 2014 Feb; 48():55-63. PubMed ID: 24361957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomics study for identification of putative drug targets in Salmonella typhi Ty2.
    Batool N; Waqar M; Batool S
    Gene; 2016 Jan; 576(1 Pt 3):544-59. PubMed ID: 26555890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Novel Putative Drugs and Vaccine Candidates against Tick-Borne Pathogens: A Subtractive Proteomics Approach.
    Ali A; Ahmad S; Wadood A; Rehman AU; Zahid H; Qayash Khan M; Nawab J; Rahman ZU; Alouffi AS
    Vet Sci; 2020 Sep; 7(3):. PubMed ID: 32906620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated in silico based subtractive genomics and reverse vaccinology approach for the identification of novel vaccine candidate and chimeric vaccine against XDR Salmonella typhi H58.
    Khan K; Jalal K; Uddin R
    Genomics; 2022 Mar; 114(2):110301. PubMed ID: 35149170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic subtractive hybridization and selective capture of transcribed sequences identify a novel Salmonella typhimurium fimbrial operon and putative transcriptional regulator that are absent from the Salmonella typhi genome.
    Morrow BJ; Graham JE; Curtiss R
    Infect Immun; 1999 Oct; 67(10):5106-16. PubMed ID: 10496884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori.
    Dutta A; Singh SK; Ghosh P; Mukherjee R; Mitter S; Bandyopadhyay D
    In Silico Biol; 2006; 6(1-2):43-7. PubMed ID: 16789912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtractive Genomics Approach for Identification of Novel Therapeutic Drug Targets in
    Fatoba AJ; Okpeku M; Adeleke MA
    Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451385
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of a subtractive genomics approach for in silico identification and characterization of novel drug targets in Mycobacterium tuberculosis F11.
    Hosen MI; Tanmoy AM; Mahbuba DA; Salma U; Nazim M; Islam MT; Akhteruzzaman S
    Interdiscip Sci; 2014 Mar; 6(1):48-56. PubMed ID: 24464704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide Core Proteome Analysis of Brucella melitensis Strains for Potential Drug Target Prediction.
    Rahman N; Shah M; Muhammad I; Khan H; Imran M
    Mini Rev Med Chem; 2021; 21(18):2778-2787. PubMed ID: 32634082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genomic analysis of Rickettsia rickettsii for identification of drug and vaccine targets: tolC as a proposed candidate for case study.
    Maurya PK; Singh S; Mani A
    Acta Trop; 2018 Jun; 182():100-110. PubMed ID: 29474831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational subtractive genome analysis for the characterization of novel drug targets in Klebsiella pneumonia strain PittNDM01.
    Rafiq H; Ullah K; Ahmad B; Rehman AU; Shah MK; Khan A; Uddin R; Azam SS; Wadood A
    Microb Pathog; 2020 Sep; 146():104245. PubMed ID: 32423883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.